Actividades asistenciales
Otsanimodi tai sen farmaseuttisesti hyväksyttävä suola, erityisesti otsanimodihydrokloridi
18/11/2020 -
Pharmaceutical granulations having a functional coating surrounding a core containing a water-soluble active pharmaceutical ingredient are disclosed. The functional coating provides for immediate...
BCMA-gerichtete CAR-T-Zelltherapie für Multiples Myelom
20/02/2026 -
The present invention relates to the field of pharmaceuticals, gene therapy and medicine, specifically to pharmaceutical compositions of a vector based on recombinant non-enveloped virus, in...
DESIGN-AREA-BASED CONTEXTUAL RESIZING AND FILLING IN
19/03/2026 -
In some embodiments, a method for generating digital image extensions contextually based on a custom image comprises: determining one or more regions that are to be outside of a custom image once...
Investigating the Effect of Prior Exposure and Fidelity on Quality and Realism Perception of VR Digital Twins
12/03/2026 -
A system and method is provided for displaying surfaces of an object from a vantage point different from the vantage point from which imagery of the object was captured. In some aspects, imagery...
KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
24/11/2023 -
La presente invención se refiere al campo técnico de los sistemas de administración para ingredientes activos agroquímicos o ingredientes activos farmacéuticos. La presente invención se...
HAO1(ヒドロキシ酸オキシダーゼ1(グリコール酸オキシダーゼ))遺伝子の発現の阻害のための組成物および方法
10/03/2026 -
...
Correction: Emerging Therapeutics in Rheumatoid Arthritis
19/10/2023 -
Provided herein are stable aqueous pharmaceutical compositions comprising high concentration formulations of a bispecific epidermal growth factor receptor (EGFR)/hepatocyte growth factor receptor...
Two roads to thermogenesis: vascular and parenchymal sympathetic innervation of brown adipose tissue
19/05/2025 -
La presente invención se refiere a una composición farmacéutica orodispersable de liberación inmediata, que comprende una mezcla eutéctica de clonazepam y una matriz polimérica hidrofílica....
COMPOUNDS FOR TARGETING DEGRADATION OF BRUTON'S TYROSINE KINASE
31/10/2023 -
This disclosure relates to compounds of Formula (A): BTK— L— DSM (A) or a pharmaceutically acceptable salt thereof, wherein DSM is a degradation signaling moiety that is covalently attached to...
ANTI CCR8 ANTIBODY THERAPY: BIOMARKERS and COMBINATION THERAPIES
27/12/2022 -
The present invention relates to tools and methods for the generation of antibodies which specifically bind chemokine receptors, such as CC or CXC chemokine receptors. Provided are isolated...
MHC CLASS I CHAIN-RELATED PROTEIN A (MICA)-SPECIFIC ANTIBODIES AND USES THEREOF
14/12/2025 -
The present disclosure relates to the treatment of cancer. In particular, the present disclosure provides novel therapeutic antibodies that target MHC Class I Chain-Related Protein A (MICA) in a...
Biotic homogenization and differentiation effects of fragmentation vary with spatial scale for multiple levels of understory bird diversity in northwest Ecuador
09/08/2023 -
Se proporciona un polipéptido mutante de hidroxifenilpruvato dioxigenasa, un gen codificador y el uso del mismo. El polipéptido mutante de la hidroxifenilpiruvato dioxigenasa conserva la...
SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS
30/11/2025 -
The present invention relates to novel spiro-macrocyclic compounds of general formula (I) which are Orexin 2 receptor agonists.
HIGH AFFINITY ANTIBODIES TARGETING TAU PHOSPHORYLATED AT SERINE 413
22/12/2022 -
Provided herein are high affinity antibodies or antigen binding fragments thereof that specifically bind to human tau-pS413. Also provided are compositions, kits, methods, and uses involving such...
RIP1K INHIBITORS
29/12/2022 -
Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising...
CODON-OPTIMIZED NUCLEIC ACID ENCODING SMN1 PROTEIN
01/12/2022 -
The present application relates to the field of genetics, gene therapy and molecular biology. More specifically, the present invention relates to an isolated codon-optimized nucleic acid encoding...
MOLÉCULA DE siRNA PARA INHIBIR LA EXPRESIÓN DE PCSK9 Y USO DE LA MISMA
04/02/2026 -
La presente invención se refiere al campo técnico de la terapia génica, y, específicamente, a una molécula de siRNA (small interference RNA, por sus siglas en inglés, ARN pequeño de...
Actividades asistenciales
Agroalimentación
Automoción y nueva movilidad
Energía sostenible y eficiente
Materiales avanzados
Medio ambiente y sostenibilidad
Patrimonio natural y cultural
Procesos productivos e industria 4.0
Química y biotecnología
Salud y calidad de vida
Transformación digital



